E-LIB Suche - Ergebnisse für: Tehfe, Mustapha

1

Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite S..:

Kim, Richard ; Tehfe, Mustapha ; Kavan, Petr...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 118-127.e6 , 2024

Link: https://doi.org/10.1016/..

2

Pembrolizumab Plus Binimetinib With or Without Chemotherapy..:

Chen, Eric X. ; Kavan, Petr ; Tehfe, Mustapha...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 183-193 , 2024

Link: https://doi.org/10.1016/..

3

Best Practices for Managing Patients with Unresectable Meta..:

Snow, Stephanie ; Gabrielson, Denise ; Lim, Howard..
Current Oncology. 31 (2024) 5 - p. 2552-2565 , 2024

Link: https://doi.org/10.3390/..

4

FRI498 Paraneoplastic Hyperthyroidism In A Patient With B-h..:

Perreault, Florence ; Tehfe, Mustapha ; Laskine, Mikhael...
Journal of the Endocrine Society. 7 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1210/..

5

A plain language summary of the CheckMate 649 study: nivolu..:

Janjigian, Yelena Y ; Shitara, Kohei ; Moehler, Markus...
Future Oncology. 19 (2023) 11 - p. 739-752 , 2023

Link: https://doi.org/10.2217/..

6

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutati..:

Proulx-Rocray, Francis ; Routy, Bertrand ; Nassabein, Rami...
Cancer Treatment and Research Communications. 37 (2023) - p. 100767 , 2023

Link: https://doi.org/10.1016/..

7

A Phase II Exploratory Study to Identify Biomarkers Predict..:

Gambaro, Karen ; Marques, Maud ; McNamara, Suzan...
International Journal of Molecular Sciences. 25 (2023) 1 - p. 43 , 2023

Link: https://doi.org/10.3390/..

8

Phase II multicenter trial combining nivolumab and radiosur..:

Wong, Philip ; Masucci, Laura ; Florescu, Marie...
Neuro-Oncology Advances. 5 (2023) 1 - p. , 2023

Link: https://doi.org/10.1093/..

9

Systemic inflammatory prognostic scores in advanced pancrea..:

Ma, Lucy X. ; Wang, Yifan ; Espin-Garcia, Osvaldo...
British Journal of Cancer. 128 (2023) 10 - p. 1916-1921 , 2023

Link: https://doi.org/10.1038/..

10

Current and Emerging Role of Monoclonal Antibody-Based Firs..:

Désilets, Audrey ; Elkhoury, Reem ; Gebai, Ahmad.
Current Oncology. 30 (2023) 10 - p. 9304-9316 , 2023

Link: https://doi.org/10.3390/..

11

A Phase II Exploratory Study to Identify Biomarkers Predict..:

Gambaro, Karen ; Marques, Maud ; McNamara, Suzan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10778949/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Current and Emerging Role of Monoclonal Antibody-Based Firs..:

Audrey Désilets ; Reem Elkhoury ; Ahmad Gebai.
https://www.mdpi.com/1718-7729/30/10/672. , 2023

Link: https://doi.org/10.3390/..

13

A Phase II Exploratory Study to Identify Biomarkers Predict..:

Karen Gambaro ; Maud Marques ; Suzan McNamara...
https://www.mdpi.com/1422-0067/25/1/43. , 2023

Link: https://doi.org/10.3390/..

14

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutati..:

Francis Proulx-Rocray ; Bertrand Routy ; Rami Nassabein...
http://www.sciencedirect.com/science/article/pii/S2468294223000898. , 2023

Link: https://doi.org/10.1016/..

15

The CCTG PA.7 phase II trial of gemcitabine and nab-paclita..:

Renouf, Daniel J. ; Loree, Jonathan M. ; Knox, Jennifer J....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..